Olopatadine HCL 0.1% Ophthalmic Solution
DLA Troop Support · DLA TROOP SUPPORT
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation SPE2D222R0117 in this department, oldest first.
- May 4, 2026Award NoticeGOLDEN STATE MEDICAL SUPPLY INC · $17.6MOpen
- Sep 24, 2026 · this noticeAward NoticeGOLDEN STATE MEDICAL SUPPLY INC · $17.6M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Modification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience. Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 202… (show all)
6 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle
Who won similar work
35 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Golden State Medical Supply, Inc. | 9 | $205.2M | Oct 14, 2026 |
| AVKARE LLC | 4 | $29.9M | Sep 1, 2026 |
| FENWAL, INC. | 3 | $159K | May 22, 2025 |
| RADHA PHARMACEUTICALS INC | 2 | $30.8M | Sep 14, 2026 |
| OAKRIDGE DYNAMICS LLC | 2 | $115K | Aug 18, 2025 |
| THE STRONGHOLD GROUP LLC · $PWR | 2 | $88K | Jul 22, 2026 |
| SZY HOLDINGS, LLC | 2 | $78K | Sep 2, 2025 |
| DMS PHARMACEUTICAL GROUP INC | 2 | $67K | Jul 21, 2025 |
| Exelan Pharmaceuticals Inc. | 1 | $24.1M | Jun 13, 2025 |
| CHRISTOPHER I. OYOLOKOR Sr. | 1 | $14.6M | Nov 25, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 14, 2026Golden State Medical Supply, Inc.$15.3MPravastatin Solicitation
- Oct 7, 2026GOLDEN STATE MEDICAL SUPPLY INC$4.3MQuetiapine Fumarate XR Tablets
- Sep 14, 2026RADHA PHARMACEUTICALS INC$23.3MBupropion HCL ER
- Sep 9, 2026SpecGx, LLC$5.9MMethylphenidate HCL IR
- Sep 3, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$2.4MSolifenacin Award
- Sep 1, 2026AVKARE LLC$11.9MAnastrozole - Award
- Jul 24, 2026ALTITUDE TECHNOLOGIES INC.$25K65--FIRST AID KIT,UTILITY
- Jul 23, 2026PADAGIS SOURCING SOLUTIONS LLC$3.2MClindamycin Phosphate - Benzoyl Peroxide Gel
- Jul 22, 2026THE STRONGHOLD GROUP LLC$36K65--PRUSSIAN BLUE CAPSU
- Jul 22, 2026THE STRONGHOLD GROUP LLC$52K65--PRUSSIAN BLUE CAPSU
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense Logistics Agency since 2024 (0 filings)
- 0 of their lobbyists list a past Defense Logistics Agency job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.